摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

6-Bromo-11-oxa-14-selena-15,16-diazatetracyclo[8.7.0.02,7.013,17]heptadeca-1(10),2(7),3,5,8,13(17),15-heptaene | 1093743-36-2

中文名称
——
中文别名
——
英文名称
6-Bromo-11-oxa-14-selena-15,16-diazatetracyclo[8.7.0.02,7.013,17]heptadeca-1(10),2(7),3,5,8,13(17),15-heptaene
英文别名
——
6-Bromo-11-oxa-14-selena-15,16-diazatetracyclo[8.7.0.02,7.013,17]heptadeca-1(10),2(7),3,5,8,13(17),15-heptaene化学式
CAS
1093743-36-2
化学式
C13H7BrN2OSe
mdl
——
分子量
366.075
InChiKey
CRDAYFNDQCYGCF-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.01
  • 重原子数:
    18
  • 可旋转键数:
    0
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.08
  • 拓扑面积:
    35
  • 氢给体数:
    0
  • 氢受体数:
    3

反应信息

  • 作为产物:
    描述:
    [(7-bromo-2,3-dihydrobenzo[f]chromen-1-ylidene)amino]urea 在 selenium(IV) oxide 作用下, 以 溶剂黄146 为溶剂, 反应 12.0h, 以92%的产率得到6-Bromo-11-oxa-14-selena-15,16-diazatetracyclo[8.7.0.02,7.013,17]heptadeca-1(10),2(7),3,5,8,13(17),15-heptaene
    参考文献:
    名称:
    Synthesis and in vitro anti-bacterial evaluation of tetracyclic-ortho-fused 4H-naphtho[1′,2′–5,6]pyrano[3,4-d](1,2,3)selenadiazole and its derivatives
    摘要:
    Synthesis of new heterocyclic compounds 3a-e containing naphthopyran and selenadiazole as the heterocyclic sub-units in the molecule is achieved using high yielding synthetic protocol. These molecules 3a-e have shown moderate anti-bacterial activity against some gram-positive and grain-negative bacterias. (C) 2008 Elsevier Masson SAS. All rights reserved.
    DOI:
    10.1016/j.ejmech.2008.01.026
点击查看最新优质反应信息

文献信息

  • Synthesis and in vitro anti-bacterial evaluation of tetracyclic-ortho-fused 4H-naphtho[1′,2′–5,6]pyrano[3,4-d](1,2,3)selenadiazole and its derivatives
    作者:A.V. Karnik、A.M. Kulkarni、N.J. Malviya、B.R. Mourya、B.L. Jadhav
    DOI:10.1016/j.ejmech.2008.01.026
    日期:2008.11
    Synthesis of new heterocyclic compounds 3a-e containing naphthopyran and selenadiazole as the heterocyclic sub-units in the molecule is achieved using high yielding synthetic protocol. These molecules 3a-e have shown moderate anti-bacterial activity against some gram-positive and grain-negative bacterias. (C) 2008 Elsevier Masson SAS. All rights reserved.
查看更多